Abstract. Background: Oesophageal squamous cell carcinoma (ESCC) and colorectal cancer (CRC) are common types of human cancer. Spheroid colony formation is used to characterize cancer stem cell (CSCsGastrointestinal (GI) cancer, including oesophageal squamous cell carcinoma (ESCC), gastric cancer (GC), and colorectal cancer (CRC), are common malignancies worldwide. A variety of genetic and epigenetic alterations are associated with GI cancer, and better knowledge of the changes in gene expression that occur during gastric carcinogenesis may lead to improvements in diagnosis, treatment, and prevention (1). Genes encoding transmembrane/secretory proteins that are specifically expressed in cancer are ideal diagnostic biomarkers. Moreover, if the gene product functions in the neoplastic process, the gene is not just a potential biomarker, but may also be a therapeutic target (2).In the past decade, cancer has been recognized as a stem cell disease (3). Cancer stem cells (CSCs) are defined as malignant cells that possess the ability to initiate tumour growth and sustain self-renewal (4). Moreover, CSCs play an important role in resistance to chemotherapy (4). Therefore, characterization of CSCs is important for establishing more effective cancer treatments. One useful method for characterizing CSCs is spheroid colony formation. We previously showed that KIF11 and kinesin family C1 (KIFC1) genes are more highly expressed, by more than two-fold, in spheroid-forming cells than in the parental cells of GC cell lines (5). We also showed that KIF11 protein expression is upregulated in GC tissue samples, and that both the number and size of spheres produced by GC cells are significantly reduced by inhibition of KIF11 (6). These results suggest that KIF11 likely plays an important role in gastric CSCs.KIF11 (also known as EG5) is a member of the kinesin superfamily. The kinesin superfamily proteins are classified as mitotic kinesins, which are involved in cell division, and non-mitotic kinesins, which are principally involved in intracellular transport (7). KIF11 is a mitotic kinesin and is required for the separation of duplicated centrosomes during spindle formation (8). Thus, a KIF11 inhibitor is thought to be useful to specifically target proliferating tumour tissue (9). Several small molecule KIF11 inhibitors have been reported (10). There is a possibility that KIF11 inhibitors 47